The Joint Corp.
$8.41
The Read: stock remained largely flat around its Q4 2025 and Q1 2026 earnings releases despite solid 13% revenue growth and 22% adjusted EBITDA gains, as in-line EPS and already priced-in optimism on its refranchising progress limited upside.
Price
Overlays
Panel
JYNT
Hover to view data
No Data